BDX vs DXCM: stock comparison and AI forecast
Becton Dickinson & Co (BDX) and Dexcom Inc (DXCM) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BDX Becton Dickinson & Co
- Price
- $211.88 +38.2% · 6M
- Market Cap
- $57.71B
- P/E Ratio
- 68.8x
- Size
- large-cap
- AI Forecast
DXCM Dexcom Inc
- Market Cap
- $29.62B
- P/E Ratio
- 28.9x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- BDX is 1.9 times larger than DXCM by market capitalization ($57.71B against $29.62B).
- DXCM trades at 28.9 times trailing earnings, BDX at 68.8 times.
- DXCM turns 19.4% of its revenue into net income, against 4.7% for BDX.
- DXCM carries 1.46 times debt per unit of equity, against 1.08 times for BDX.
- BDX yields 2.03% in dividends; DXCM pays none.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BDX | DXCM |
|---|---|---|
| Market Cap | $57.71B | $29.62B |
| P/E Ratio | 68.79x | 28.88x |
| P/B Ratio | 2.36x | 11.68x |
| Dividend Yield | 2.03% | – |
| EPS | $3.08 | $2.75 |
| Book Value/Share | $89.64 | $6.80 |
| Revenue/Share | $73.70 | $13.69 |
| FCF/Share | $9.30 | $2.94 |
Profitability & Margins
| Metric | BDX | DXCM |
|---|---|---|
| ROE | 3.9% | 39.1% |
| ROA | 1.9% | 15.9% |
| ROIC | 4.7% | 30.7% |
| Gross Margin | 46.4% | 63.4% |
| Operating Margin | 9.6% | 24.0% |
| Net Margin | 4.7% | 19.4% |
| EBT Margin | 7.0% | 24.7% |
| Tax Rate | 13.7% | 21.5% |
Financial Health
| Metric | BDX | DXCM |
|---|---|---|
| Current Ratio | 0.87x | 1.74x |
| Quick Ratio | 0.51x | 1.40x |
| D/E Ratio | 1.08x | 1.46x |
| Financial Leverage | 2.08x | 2.46x |
| Interest Coverage | 1.1x | 155.8x |
| Working Capital | -$1.26B | $1.66B |
Cash Flow
| Metric | BDX | DXCM |
|---|---|---|
| Operating Cash Flow | $3.26B | $1.41B |
| Free Cash Flow | $2.53B | $1.10B |
| Capital Spending | -$728M | -$316M |
| OCF Growth YoY | 0.2% | -2.3% |
| FCF Growth YoY | -0.7% | 3.4% |
| FCF/Sales | 12.6% | 21.5% |
| CapEx/Sales | 3.6% | 6.2% |
Operational Efficiency
| Metric | BDX | DXCM |
|---|---|---|
| Asset Turnover | 0.40x | 0.82x |
| Receivables Turnover | 8.5x | 4.3x |
| Inventory Turnover | 3.2x | 2.4x |
| Fixed Assets Turnover | 3.3x | 3.3x |
| Days Sales Outstanding | 43 days | 85 days |
| Days Inventory | 113 days | 151 days |
| Payables Period | 207 days | 404 days |
| Cash Conversion Cycle | -52 days | -168 days |
Income Statement
| Metric | BDX | DXCM |
|---|---|---|
| Total Revenue | $20.07B | $5.10B |
| Operating Income | $1.92B | $1.22B |
| Net Income | $942M | $991M |
| R&D Expense | $1.06B | $608M |
| SG&A Expense | $5.07B | $1.41B |
| Cost of Goods Sold | $10.75B | $1.87B |
Dividend & Shareholder Information
| Metric | BDX | DXCM |
|---|---|---|
| Dividends Per Share | $4.30 | – |
| Payout Ratio | 139.6% | – |
| Shares Outstanding | 272M | 373M |
| Net Income Growth | -40.6% | 37.5% |
| EPS Growth | -52.2% | 54.5% |
BDX vs DXCM: stock comparison and AI forecast
Which is bigger, BDX or DXCM?
BDX is 1.9 times larger than DXCM by market capitalization ($57.71B against $29.62B).
Which is cheaper on earnings, BDX or DXCM?
DXCM trades at 28.9 times trailing earnings, BDX at 68.8 times.
Which one does Intratio's AI model rank higher, BDX or DXCM?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.